“Efficacy of Difelikefalin in Subjects With Moderate-to-Severe Chronic Kidney Disease–Associated Pruritus: Pooled Subgroup Analysis of KALM-1 and KALM-2”, J of Skin, vol. 5, no. 6, p. s77, Nov. 2021, doi: 10.25251/skin.5.supp.77.